Loading clinical trials...
Loading clinical trials...
Gynaecological Follow-up of a Subset of HPV-015 Study Subjects
Conditions
Interventions
Gynaecological follow-up
Cervarix
+1 more
Locations
20
United States
GSK Investigational Site
Iowa City, Iowa, United States
GSK Investigational Site
Wichita, Kansas, United States
GSK Investigational Site
Wenatchee, Washington, United States
GSK Investigational Site
Edmonton, Alberta, Canada
GSK Investigational Site
Vancouver, British Columbia, Canada
GSK Investigational Site
Halifax, Nova Scotia, Canada
Start Date
September 12, 2011
Primary Completion Date
September 20, 2017
Completion Date
September 20, 2017
Last Updated
October 30, 2019
NCT01627561
NCT00196937
NCT01462357
NCT01277042
NCT00345878
NCT00426361
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions